(2021) found that GLP-1 could improve the cognition of mice by enhancing aerobic glycolysis and reducing the levels of oxidative phosphorylation and oxidative stress in the brain
Tirzepatide is classified by the ADA as a GIP/GLP-1 receptor agonist, and retatrutide would fall into the same functional category for the purpose of this recommendation
Omega-3 fatty acids , the EPA and DHA in fish oil that form part of every neuronal membrane, are mixed to null as a cognitive enhancer in healthy adults
Major confounding variable
Clinical studies have shown that individuals can experience a weight reduction of approximately 24% of their total body weight during this period
Studies were eligible if they compared the efficacy of GLP-1 RAs, such as liraglutide or exenatide, with placebo, no treatment, or any other intervention, including testosterone replacement therapy (TRT)